TIDMFITB

RNS Number : 4451K

Fitbug Holdings PLC

21 September 2016

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014 (MAR).

Fitbug Holdings plc

(the "Company" or the "Group")

Interim Results for the six Months Ended 30 June 2016

Fitbug Holdings Plc, the AIM quoted provider of corporate wellness solutions and services, announces its Interim Results for the six months ended 30 June 2016.

Highlights:

   --      Implementation of turnaround strategy away from retail to Corporate Wellness 
   --      Total sales of GBP729,000 (2015: GBP991,000); 
   --      B2B sales of GBP562,219 (2015: GBP369,151); 
   --      Gross profit of GBP408,000 (2015: GBP530,000); 
   --      Loss before tax GBP(1,644,000) (2015: GBP(3,215,000)); 
   --      Good progress on Corporate Wellness offering made with three strategic partners; 

-- Significant reduction in permanent cost base and engagement of outsourced service providers for development of platform and ancillary services (IT, logistics, finance admin)

The first half of the year has produced sales in the B2B sector of GBP562,219, a 52% increase in like for like sales for 2015. Whilst overall sales for the first half were lower than the same period in 2015, the results reflect the Group's strategy to re-focus on Corporate Wellness rather than on the retail sector, a sector in which 2015's first half weighted results proved unsustainable. The Group's turnaround strategy has reduced first half losses by almost 50% in comparison with 2015.

Post period end, the Group successfully completed its GBP2.61m fundraise and the restructuring of its balance sheet through the conversion of GBP8.4m of the Group's core debt into equity.

Donald Stewart, Fitbug Chairman, commented on the results, "Fitbug has continued to focus on implementing its turnaround strategy. This involves concentrating our resources on providing digital wellness solutions to the corporate sector through our key partners. This strategy has seen encouraging progress in the first half and has allowed the Group to grow end-user engagement while simultaneously reducing our cost base significantly. With our additional working capital and reduced levels of debt following our successful fundraise in July, the Board is confident as to the Company's future prospects."

Anna Gudmundson, Fitbug CEO, added, "Having only brought the new Corporate Wellness offering to market at the end of 2015, it is great to see the Company starting to benefit from the new strategy in such a short period of time. It is still early days for our digital wellness platform but we pleased to see our clients using the service and, in the case of some large organisations, starting rollouts across thousands of employees. We have successfully restructured the Group and now have a substantially smaller, more focussed and experienced team which is accelerating our ability to deliver, as well as improving quality across all areas of the business."

For further information, visit www.fitbug.com or www.fitbugholdings.com or contact:

 
 Anna Gudmundson / Donald 
  Stewart                        Fitbug Holdings Plc          020 7449 1000 
------------------------------  ---------------------------  -------------- 
 Marc Milmo/ Catherine           Cantor Fitzgerald Europe, 
  Leftley                         Nomad and Joint Broker      020 7894 7000 
------------------------------  ---------------------------  -------------- 
 Claire Louise Noyce / 
  William Lynne / Niall          Hybridan LLP, Joint 
  Pearson                         Broker                      020 3764 2341 
------------------------------  ---------------------------  -------------- 
 Elisabeth Cowell / Charlotte    St Brides Partners 
  Heap                            Ltd, Public Relations       020 7236 1177 
------------------------------  ---------------------------  -------------- 
 

Notes

About Fitbug(R)

Fitbug provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Fitbug can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

The Company's technological edge allows us to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

Fitbug's shares are listed on the London Stock Exchange AIM market under ticker FITB.

CHAIRMAN'S STATEMENT:

The Group has experienced an encouraging start to trading in 2016 following the commencement of its turnaround strategy in the second half of 2015. The reduction in overall Group sales reflects Fitbug's strategy to move away from retail to focus on the B2B sector and whilst sales revenues are down against the same period last year, the first half of 2016 produced sales in the B2B sector of GBP562,219, a significant increase over sales in this sector from 2015 (2015: GBP369,151). The Group's results were greatly improved with significant orders from a South African partner which are expected to continue to be rolled out throughout the remainder of 2016.

The key development of the period was the publication, on 29 June, of the Company's proposals to raise GBP2.61m of additional funds and to significantly restructure its balance sheet through the conversion of GBP8.4m of the Group's core debt into equity. These proposals were approved by shareholders on 22 July and the fundraising was completed successfully on 25 July. In addition, on 25 July the Company adopted two new share option schemes, an Enterprise Management Incentive scheme and an Unapproved Scheme and granted options over 9.24% of the enlarged issued share capital of the Company pursuant to these new schemes.

Outlook

During the remainder of the second half of the current financial year, the Directors will continue to build upon the B2B success to date, concentrating the Group's resources on providing digital wellness solutions to the corporate sector through its key partners. As previously stated, the Company has identified a low cost entry point to market via relationships with strategic partners.

The Group continues to focus on its pipeline of potential B2B opportunities working closely with Willis Towers Watson in South East Asia and its other key strategic partners to explore further roll out opportunities. As previously announced, Punter Southall Health & Protection Consulting Limited extended Fitbug's Digital Wellness Solution to four of its clients between November 2015 and February 2016. In addition, the Group is simultaneously reducing its costs significantly in order to reach its goal of reducing its expenses by over 30 per cent. in the current financial year.

Fitbug is working in a fast expanding market space, offering wellness services to a growing number of global corporate clients. Its goal is to help substantial organisations create a culture of wellness that increases employee productivity and reduces healthcare costs by helping to promote and engage employees in living a more positive lifestyle. Fitbug has created a simple, powerful and high value Digital Wellness solution that engages users by making this process personal and fun.

Fitbug Holdings plc

Consolidated statement of comprehensive income

for the period ended 30 June 2016

 
                                                                Unaudited 6 months   Unaudited 6 months        Audited 
                                                                                                                  Year 
                                                                             ended                ended          Ended 
                                                                           30 June              30 June    31 December 
                                                                              2016                 2015           2015 
                                                         Note              GBP'000              GBP'000        GBP'000 
 
 
 Continuing operations 
 Revenue                                                                       729                  991          1,259 
 Cost of sales - normal                                                      (299)                (461)          (647) 
                                                                      ------------         ------------   ------------ 
 Gross profit before exceptional items                                         430                  530            612 
 Exceptional write down of obsolete inventory                                    -                    -          (736) 
                                                                      ------------         ------------   ------------ 
 Gross profit                                                                  430                  530          (124) 
 
 Operating and administrative expenses - normal                            (1,939)              (3,074)        (5,241) 
 Operating and administrative expenses - exceptional                             -                (467)        (1,162) 
 Finance income                                                                  -                    -              2 
 Finance costs                                                               (137)                (204)            (5) 
                                                                      ------------         ------------   ------------ 
 Loss for the period before tax                                            (1,646)              (3,215)        (6,530) 
 
 Income tax                                                                      -                    -            227 
                                                                      ------------         ------------   ------------ 
 Loss for the period and total comprehensive income 
  for the period attributable to equity holders 
  of the parent                                                            (1,646)              (3,215)        (6,303) 
                                                                      ------------         ------------   ------------ 
 
 Loss per share                                           2                  (0.6)                (1.3)          (2.5) 
                                                                      ------------         ------------   ------------ 
 
 

Fitbug Holdings plc

Consolidated statement of changes in equity

for the six months ended 30 June 2016

 
                                                              Share          Share       Retained          Total 
                                                            capital        Premium        deficit         Equity 
                                                            GBP'000        GBP'000        GBP'000        GBP'000 
 Balance at 1 January 2015 (audited)                          2,408          4,144        (9,853)        (3,301) 
 
 Loss and total comprehensive income for the period               -              -        (3,215)        (3,215) 
 Share based payment                                              -              -            281            281 
                                                       ------------   ------------   ------------   ------------ 
 Balance at 30 June 2015 (unaudited)                          2,408          4,144       (12,787)        (6,235) 
 
 Loss and total comprehensive income for the period                                       (3,088)        (3,088) 
 Issue of shares for cash                                       407            609              -          1,016 
 Costs of raising funds                                           -           (38)              -           (38) 
 Share based payment                                              -              -            192            192 
                                                       ------------   ------------   ------------   ------------ 
 Balance at 31 December 2015 (audited)                        2,815          4,715       (15,683)        (8,153) 
 
 Loss and total comprehensive income for the period               -              -        (1,646)        (1,646) 
 Share based payment                                              -              -              2              2 
                                                       ------------   ------------   ------------   ------------ 
 Balance at 30 June 2016 (unaudited)                          2,815          4,715       (17,327)        (9,797) 
                                                       ------------   ------------   ------------   ------------ 
 

Fitbug Holdings plc

Consolidated Balance Sheet

at 30 June 2016

 
                                     Unaudited      Unaudited        Audited 
                                      6 months       6 months           Year 
                                         Ended          Ended          Ended 
                                       30 June        30 June    31 December 
                                          2016           2015           2015 
                                       GBP'000        GBP'000        GBP'000 
 Assets 
 Non-current assets 
 Intangible assets                           -            523              - 
 Property, plant and equipment              30             32             29 
                                  ------------   ------------   ------------ 
 Total non-current assets                   30            555             29 
                                  ------------   ------------   ------------ 
 Current assets 
 Inventories                               481          1,243            577 
 Trade and other receivables               242            508            751 
 Cash and cash equivalents                  65            795            698 
                                  ------------   ------------   ------------ 
 Total current assets                      788          2,546          2,026 
                                  ------------   ------------   ------------ 
 Total assets                              818          3,101          2,055 
                                  ------------   ------------   ------------ 
 Liabilities 
 Non-current liabilities 
 Borrowings                              9,140          6,939          8,739 
                                  ------------   ------------   ------------ 
 Total non-current liabilities           9,140          6,939          8,739 
                                  ------------   ------------   ------------ 
 Current liabilities 
 Trade and other payables                  900          1,322            894 
 Borrowings                                575          1,075            575 
                                  ------------   ------------   ------------ 
 Total current liabilities               1,475          2,397          1,469 
                                  ------------   ------------   ------------ 
 Total liabilities                      10,615          9,336         10,208 
                                  ------------   ------------   ------------ 
 Net liabilities                       (9,797)        (6,235)        (8,153) 
                                  ------------   ------------   ------------ 
 Capital and reserves 
 Share capital                           2,815          2.408          2,815 
 Share premium                           4,715          4,144          4,715 
 Retained deficit                     (17,327)       (12,787)       (15,683) 
                                  ------------   ------------   ------------ 
 Total equity                          (9,797)        (6,235)        (8,153) 
                                  ------------   ------------   ------------ 
 

Fitbug Holdings plc

Consolidated cash flow statement

for the six months ended 30 June 2016

 
 
                                                                               Unaudited      Unaudited      Unaudited 
                                                                              Six months     Six months      12 Months 
                                                                                   Ended          Ended          ended 
                                                                                 30 June        30 June   31December 
                                                                                    2016           2015           2015 
                                                                                 GBP'000        GBP'000        GBP'000 
 
 Cash flows from operating activities 
 Loss before taxation                                                            (1,646)        (3,215)        (6,303) 
 Adjustments for: 
 - Depreciation and amortisation                                                       7             76             82 
 - Share-based payments                                                              475            281            473 
 - FX gain loss                                                                    (625)              -           (74) 
 - Adjustment on consolidation                                                       162              -           (66) 
 - Finance income                                                                      -              -            (2) 
 - Finance expense                                                                   137            204              5 
 - Returns provision                                                               (110)              -            216 
 - Write off of development costs                                                      -              -            569 
 - Impairment of stock                                                                22              -            736 
                                                                            ------------   ------------   ------------ 
 Cash flows from operating activities before changes in working capital 
  and provisions                                                                 (1,578)        (2,654)        (4,364) 
 - Decrease in inventories                                                           164             19            206 
 - Decrease in trade and other receivables                                           520            350             95 
 - Increase/(decrease) in trade and other payables                                     4              3          (797) 
                                                                            ------------   ------------   ------------ 
 Net cash used in operations                                                       (883)        (2,282)        (4,860) 
                                                                            ------------   ------------   ------------ 
 Cash flow from investing activities 
 Purchase of property, plant and equipment                                           (7)           (22)             26 
 Development costs capitalised                                                         -          (122)          (167) 
 Finance income                                                                        -              -              2 
                                                                            ------------   ------------   ------------ 
 Net cash used in investing activities                                               (7)          (144)          (139) 
                                                                            ------------   ------------   ------------ 
 Cash flow from financing activities 
 Issue of ordinary shares for cash                                                     -              -          1,015 
 Costs directly related to issue of shares                                             -              -           (38) 
 Loan advances                                                                       401              -          1,300 
 Loan repayments                                                                       -              -              - 
 Finance expense                                                                   (144)          (204)            (5) 
                                                                            ------------   ------------   ------------ 
 Net cash generated from financing activities                                        257          (204)          2,272 
                                                                            ------------   ------------   ------------ 
 Net decrease in cash and cash equivalents                                         (633)        (2,630)        (2,727) 
 
 Cash and cash equivalents at beginning of period                                    698          3,425          3,425 
                                                                            ------------   ------------   ------------ 
 Cash and cash equivalents at end of period                                           65            795            698 
                                                                            ------------   ------------   ------------ 
 
 
 

Fitbug Holdings plc

Unaudited notes forming part of the consolidated interim financial statements

for the six months ended 30 June 2016

   1      BASIS OF PREPARATION 

Fitbug Holdings plc is a public company incorporated in England under the Companies Act 2006. Its registered office address is Suite 5, 1(st) Floor, 5 Rochester Mews, London NW1 9JB.

These condensed consolidated interim financial statements of the Company for the six months ended 30 June 2016 comprise the Company and its subsidiaries (together referred to as "the Group"). These interim statements do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The interim financial information has been prepared using the same accounting policies, presentation, method of computation and estimation techniques as are expected to be adopted in the Group financial statements for the year ending 31 December 2016 and which were adopted in the audited Group financial statements for the year ended 31 December 2015.

The financial information for the year ended 31 December 2015 has been extracted from the statutory accounts for that period. The auditors have reported on the statutory accounts for the year ended 31 December 2015 and their report was unqualified. The auditors' report drew attention by emphasis of matter to issues surrounding the ability of the Company to continue as going concern. A copy of those financial statements has been filed with the Registrar of Companies.

These condensed consolidated interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted in the EU. While the financial figures included in this half yearly report have been computed in accordance with IFRSs as adopted in the EU applicable to interim periods, this half yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

   2      LOSS PER SHARE 

The loss per share is based on a loss for the period attributable to equity holders of the Company of GBP1,644,000 (2015: loss of GBP3,215,000) and the weighted average number of ordinary shares being in issue for the period of 281,450,530 (2015: 240,850,530).

The exercise of the options outstanding as at 30 June 2016 would reduce the loss per share and hence have an anti-dilutive effect. As at 30 June 2016 there were 50,000 (2015: 21,100,000) shares that could potentially have been issued under the terms of options and a further 33,333,334 shares that could have been potentially issued under the terms of convertible loans that would potentially reduce future earnings per share.

   3     GOING CONCERN 

These condensed interim financial statements for the six months ended 30 June 2016 have been prepared on the assumption that the Group will be able to continue trading as a going concern for the foreseeable future. As at 30 June 2016 the Group had outstanding loans of GBP9,640,000, which included GBP1m in loans from Kifin Limited, a Kirsh Group subsidiary, (including a GBP500,000 loan issued under a convertible loan note instrument dated 28 June 2012) and loans of a further GBP8,640,300 from NW1 Investments Limited, a company connected to two of the former directors of the Group.

The directors have prepared these interim financial statements on the basis that the Group is a going concern as the successful completion of the Group's GBP2.61m fundraising and the restructuring of its balance sheet in late July 2016 together with the Group's anticipated sales pipeline is expected to provide the Group's with working capital sufficient for its requirements for at least the next 12 months. The Group's sales forecasts are, however, based on the achievement of and timings of revenue forecasts which, although believed reasonable by the directors are nevertheless, in part, outside the Group's direct control. If significant delays were to take place, these may render the Group's cash resources insufficient.

If as a result the Group were unable to continue as a going concern, then adjustments would be necessary to write assets down to their recoverable amounts, non-current assets and liabilities would be reclassified as current assets and liabilities and provisions would be required for any costs associated with closure.

   4      SUBSEQUENT EVENTS 

The Company announced the results of a new fundraising and debt re-profiling on 22(nd) July 2016:

On 22(nd) July 2016 each of the Company's existing ordinary shares of 1p each were subdivided into one new ordinary share of 0.1p and one deferred share of 0.9p.

GBP2.61m (before expenses) was raised by the issue of 613,916,438 new Ordinary Shares at 0.25p per share and the creation of GBP1,076,275 of new loan notes.

Additionally, a further 336,000,000 new Ordinary Shares were issued at 2.5p per share to capitalise GBP8.4m of loans due to two investors.

This strong support from key stakeholders not only provides the Company with additional funding but also reduces its interest charge.

   5     BOARD CHANGES 

During the period under review, the Company appointed Dr Mark Ollila to the Board as a non-executive director on 8 January 2016. Mark is based in San Diego and has held numerous senior positions in mobile media and technology.

The Company also announced on 29(th) June the appointment of Tyler Tarr to the Board as part time finance director and the resignations of David Turner and Allan Fisher, both non-executive directors. Tyler has worked with the Company as interim CFO since December 2015 and has a wealth of experience in managing the finances of technology companies.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR LLFIIATILFIR

(END) Dow Jones Newswires

September 21, 2016 06:15 ET (10:15 GMT)

Kin (LSE:KIN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Kin Charts.
Kin (LSE:KIN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Kin Charts.